Use of recombinant human granulocyte macrophage colony-stimulating factor to speed engraftment and treat graft failure following marrow transplantation in man.
Appelbaum
F R
FR
Fred Hutchinson Cancer Research Center, Seattle, Washington.
Nemunaitis
J
J
Singer
J W
JW
Buckner
C D
CD
Storb
R
R
Thomas
E D
ED
D000380:Agranulocytosis / Q000209:etiology / Q000628:therapy; D016026:Bone Marrow Transplantation / Q000009:adverse effects; D003115:Colony-Stimulating Factors / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D004311:Double-Blind Method; D006084:Graft Rejection / Q000187:drug effects; D006085:Graft Survival / Q000187:drug effects*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D006133:Growth Substances / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D010865:Pilot Projects; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins / Q000627:therapeutic use
D003115:Colony-Stimulating Factors; D006133:Growth Substances; D011994:Recombinant Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor